Pure Global AI
Disease / condition

Tuberculosis clinical trials

Free access to 552 studies10+ countriesUpdated daily75 recruiting
VerifiedClinicalTrials.gov · WHO ICTRP · regional registries
552
Total trials
10+
Countries
10+
Sponsors
75
Recruiting
By phase
N/A249
Phase 1104
Phase 270
Not Applicable38
Phase 337
By status
Completed293
Unknown91
Recruiting75
Not yet recruit...59
Terminated12
Top countries
China62
South Africa57
United States of America44
United Kingdom43
South Korea19
Top sponsors
University of Oxfo...27
National Institute...23
Aeras18
Johns Hopkins Univ...13
University of Cape...13
Recent trials
Latest clinical trials for Tuberculosis
Study of GeneXpert Mycobacterium Tuberculosis/ Rifampicin (MTB/RIF) Versus the Routine Methods for Detection of Mycobacterium Tuberculosis
Sohag University
NCT06409572Not yet recr...
Evaluation of CAD-based Triage for CXR Interpretation During TB Screening
Freundeskreis Für Internationa... · Vietnam
NCT06401434Not yet recr...
A Study to Investigate the Pharmacokinetics of a Combined Oral Contraceptive When Given Alone and in Combination With GSK3036656 in Female Participants of Non-childbearing Potential Aged 18 to 65 Years of Age
GlaxoSmithKline · Spain
NCT06354257Recruiting
Phase
Phase 1
Cali Sin Tos Aim 2
Yale University · Colombia
NCT06338462Not yet recr...
Precision Rifampin Trial for Personalized Dosing
University of Virginia
NCT06318416Not yet recr...
Phase
Phase 1/2
Phase I Clinical Trial to Evaluate the Safety of Recombinant Mycobacterium Tuberculosis Fusion Protein (EEC) in Healthy Adults Aged 18-65 and Patients With Pulmonary Tuberculosis
Chengdu CoenBiotech Co., Ltd · China
NCT06224608Completed
Phase
Phase 1
Clinical Trial to Explore the Skin Test Dosage of EEC in People Aged 18 to 65 Years Old and the Safety and Preliminary Efficacy in People Aged 3 to 75 Years Old.
Chengdu CoenBiotech Co., Ltd · China
NCT06305104Recruiting
Phase
Phase 2
ThiPhiSA: New Pathways to Prevention From Community TB Screening in South Africa
University of Washington · South Africa
NCT06214910Recruiting
Phase
Phase 4
BCG Revaccination Study in Diabetic and Non-Diabetic Adults
University of Oxford · United Kingdom
NCT06246851Recruiting
Subclinical TB With Innovative Modified Short-course Regimens
Huashan Hospital · China
NCT06153069Recruitment ...
Phase
Phase 4
Clinical Presentation, and Treatment Outcomes in Tuberculous Patients in Sohag Governorate
Sohag University · Egypt
NCT06141148Recruiting
Diagnostic Innovations for Pediatric Tuberculosis in Bolivia
Tulane University
NCT06113861Not yet recr...
Study comparing anti-tuberculosis drug levels in saliva, plasma, and urine in patients
Western Sydney Local Health Di... · Australia
ANZCTR12623001088639Not yet recr...
Phase
Not Applicable
Study to Assess Efficacy and Safety of M72/AS01E-4 Mycobacterium Tuberculosis (Mtb) Vaccine in Adolescents and Adults
Bill & Melinda Gates Medical R... · Indonesia,Kenya,Malawi,Mozambique,South Africa,Vietnam,Zambia
NCT06062238Not yet recr...
Phase
Phase 3
Sensitivity and Specificity of Xpert MTB/RIF Ultra
Assiut University
NCT06058065Not yet recr...
Relevance of Isoniazid Dosage in Adults Treated for Tuberculosis
Centre Hospitalier Universitai... · France
NCT06054334Recruiting
A Retrospective Study on the Treatment Pattern and Clinical Prognosis of Severe Tuberculosis Patients
Tongji Hospital · China
NCT06021041Recruitment ...
Impact Evaluation of Use of MATCH AI Predictive Modelling for Identification of Hotspots for TB Active Case Finding
Centre for Global Public Healt...
NCT06017843Not yet recr...
Evaluating Next Generation LAM Assays and Molecular Diagnostics (POC and Near POC) for the Diagnosis of TB Among People With Presumptive TB: a Prospective Multicentre Diagnostic Accuracy Study
Foundation for Innovative New ...
NCT06019052Not yet recr...
Conducting A Study On Video Observed Therapy In The Management Of Tuberculosis
University of Malaya · Malaysia
NCT05994144Not yet recr...
About this profile

Access comprehensive clinical trial information for Tuberculosis through Pure Global AI's free database. This collection includes 552 clinical trials across multiple phases including N/A, Phase 1, Phase 2. Currently, 75 trials are actively recruiting participants.

Research for Tuberculosis is being conducted in China, South Africa, United States of America and 7+ other countries. Leading sponsors include University of Oxford and National Institute of Allergy and Infectious Diseases (NIAID). Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 552 clinical trials studying Tuberculosis, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include University of Oxford, National Institute of Allergy and Infectious Diseases (NIAID), Aeras, among others.